About the Baby Oral Care Market
The global baby oral care market will grow at a CAGR of 2.31% over the forecast period. Developing countries have seen rapid urbanization in recent years, which has led to a rise in disposable income and an increase in the number of dual-income households. These factors have had positive influences on overall spending on baby oral care products. Birth rates worldwide have declined considerably over the years. However, the negative impact of this on the market may be reduced to some extent because of growing willingness among consumers to buy high-quality products that are priced at a premium. Developing countries in APAC and Africa have huge potential for growth.
Technavio’s analysts forecast the global baby oral care market to grow at a CAGR of 2.31% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global baby oral care market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of toothbrushes and toothpastes for babies in the 0-2 age group.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Baby Oral Care Market 2016-2020
Technavio recognizes the following companies as the key players in the global baby oral care market: Colgate-Palmolive, Johnson & Johnson, Procter & Gamble (P&G), Pigeon, and Unilever.
Other Prominent Vendors in the market are: Amway, Anchor Group, Chattem, Chicco, Dabur, Dr. Fresh, GO SMiLE, Henkel, Himalaya, KAO, LG, Lion Corp., Patanjali, and Supersmile.
Commenting on the report, an analyst from Technavio’s team said: “One trend to note in the baby oral care market is the use of improved marketing strategies. Vendors are investing significantly in marketing strategies to enhance their market presence. For example, Colgate has partnered with the Indian Dental Association (IDA) and more than 30,000 dentists in India to conduct dental education programs and national and state conferences to continuously engage with consumers. These initiatives have built a strong brand image for the company. Colgate also uses superior in-store execution to make its brands more visible.”
According to the report, a key growth driver for this market is the increased preference for natural and organic oral care products. Parents are increasingly demanding natural and organic products that have no or low quantities of synthetic additives, colors, fragrances, and artificial preservatives, as these ingredients can irritate a baby’s sensitive gums. Moreover, an infant's body may not be sufficiently mature to flush out unwanted chemicals, leading to the accumulation of chemicals in the body. Natural and organic oral care products are safer and healthier for babies and toddlers than the regular commercially available products.
Further, the report states that one challenge that could restrict market growth is the threat from counterfeit products.
Acelity, Medtronic, MiMedx Group, Organogenesis, UniQure, ZimmerBiomet, ACE Surgical Supply, Acologix, Advanced Biologics, AlloCure, Allosource, Alphatec Spine, Altrika, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, Biogen Idec, BioRestorative Therapies, Biostage, BioTissue Technologies, Bluebird Bio, BONESUPPORT, BrainStorm Cell Therapies, Caladrius Biosciences, Calimmune, Capricor Therapeutics, Celgene, Cell Medica, CellSeed, Cell Therapy, Celyad, CESCA THERAPEUTICS, CRC for Cell Therapy Manuracturing, Cryolife, Cynata Therapeutics, Cytori Therapeutics, Dendreon, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, FUJIFILM, Gamida Cell, Geron, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, ImmunoCellular Therapeutics, Integra LifeSciences, Intercytex, InVivo Therapeutics, iSTO Technologies, Janssen Pharma, Juno Therapeutics, Juventas Therapeutics, Kensey Nash, Kiadis Pharma, Kinetic Concept, LifeCell, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Mesoblast, Nanofiber Solutions CTO, Nanotope, NeoStem, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata, Opexa Therapeutics, Organovo Holdings, Orteg, Orthofix, Osiris Therapeutics, Osteotech, Pfizer, Pharmicell, Pluristem Therapeutics, PrimaBioMed, Q Therapeutics, Regenerex, Regenerys, Regience, Regrow, RepliCel, ReproCELL, Renova Therapeutics, RhinoCyte, Rohto Pharmaceutical, RTI Surgical, SanBio, Sangamo BioSciences, Shanghai Sunway Biotech, Shire Regenerative Medicine, StemCells, Stratatech, Takara Bio, TEI Biosciences, tella, Tengion, Tissue Genesis, TissueGene, Txcell, VentriNova, Vericel, ViaCyte, Vistagen.